Poolbeg Pharma PLC Overview
Get informed when a big investor buys or sells
+ Follow80.95
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Poolbeg Pharma PLC (POLBF) currently reports a PEG ratio of 80.95. That is above the Healthcare sector average of 27.75. Use the charts on this page to explore Poolbeg Pharma PLC's PEG ratio history and peer comparisons.
Poolbeg Pharma PLC's PEG ratio of 80.95 is higher than the Healthcare sector average of 27.75. That is roughly 191.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates Poolbeg Pharma PLC's market price to a fundamental measure such as earnings, sales, or book value. At 80.95, POLBF can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of 80.95, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 27.75. From there, open related valuation or income-statement pages for Poolbeg Pharma PLC, and consider following POLBF for alerts when major investors trade the stock.
Poolbeg Pharma PLC is classified in the Healthcare sector. On PEG ratio, it currently shows 80.95 versus a sector average near 27.75. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing POLBF with unrelated industries.
